Safety, Tolerability, and Pharmacokinetics of Iloperidone Depot in Schizophrenic Patients
Clinical trial NCT01348100 · COMPLETED
Trial details
- NCT number
- NCT01348100
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2012-07-01
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.